Samsrita Labs Reports Q2 FY27 Results; Key Strategic Approvals Highlighted
Samsrita Labs Ltd · Outcome · 11 Nov 2026, 10:43 pm
Samsrita Labs Reports Q2 FY27 Results; Key Strategic Approvals Highlighted Samsrita Labs reported standalone net loss of ₹11.61 lakhs with nil operational revenue for the quarter ended 30th Sep'26, compared to a net loss of ₹493.50 lakhs YoY. Consolidated net loss stood at ₹28.29 lakhs against a loss of ₹454.77 lakhs YoY. Key corporate developments approved include an investment up to ₹1.00 crore in CCPS of S Labs Hygiene Care, a material related-party sales transaction with the entity up to ₹25.00 crore, and an unsecured loan up to ₹1.00 crore at 9% interest from a director.
Original exchange filing (PDF)
More announcements from Samsrita Labs Ltd
- Newspaper Publication · 13 Nov 2026
- Statement of Deviation/Variation for the quarter ended 30.09.2026 · 11 Nov 2026
- un-audited financial results for the quarter ended 30.09.2026 · 11 Nov 2026
- Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve 1. unaudited Standalone and Consolidated .... · 11 Nov 2026
- Scrutinizer Report · 27 Oct 2026
- outcome of EGM held on 26.10.2026 · 27 Oct 2026
- Intimation regarding Alteration of Memorandum of Association of the Company · 10 Oct 2026
- Submission of Notice of EGM of the Company to be held on 26.10.2026 · 03 Oct 2026
